Serina Therapeutics, Inc.
SER
$5.65
$0.152.73%
AMEX
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 6.81% | 24.78% | |||
| Gross Profit | -2.41% | -24.04% | |||
| SG&A Expenses | -12.52% | 71.61% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.78% | 44.32% | |||
| Operating Income | 5.00% | -43.83% | |||
| Income Before Tax | -34.01% | -75.22% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -34.01% | -75.22% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 55.56% | -25.00% | |||
| Net Income | -33.97% | -75.66% | |||
| EBIT | 5.00% | -43.83% | |||
| EBITDA | 5.00% | -45.41% | |||
| EPS Basic | -33.02% | 16.59% | |||
| Normalized Basic EPS | -30.62% | -81.60% | |||
| EPS Diluted | -33.79% | -64.11% | |||
| Normalized Diluted EPS | -30.62% | -81.60% | |||
| Average Basic Shares Outstanding | 2.54% | -47.37% | |||
| Average Diluted Shares Outstanding | 2.54% | -47.37% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||